Genertec Universal Medical Group Company Limited

F:5UM Germany Credit Services
Market Cap
$1.32 Billion
€1.29 Billion EUR
Market Cap Rank
#9102 Global
#985 in Germany
Share Price
€0.64
Change (1 day)
+0.00%
52-Week Range
€0.54 - €0.73
All Time High
€0.82
About

Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the People's Republic of China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; accounts receivable factoring; operating leases; and advisory services. Its… Read more

Genertec Universal Medical Group Company Limited (5UM) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2023: -0.085x

Based on the latest financial reports, Genertec Universal Medical Group Company Limited (5UM) has a cash flow conversion efficiency ratio of -0.085x as of June 2023.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.67 Billion) by net assets (€19.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Genertec Universal Medical Group Company Limited - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Genertec Universal Medical Group Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Genertec Universal Medical Group Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genertec Universal Medical Group Company Limited ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Genertec Universal Medical Group Company Limited (2016–2024)

The table below shows the annual cash flow conversion efficiency of Genertec Universal Medical Group Company Limited from 2016 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €22.87 Billion €1.14 Billion 0.050x -79.70%
2023-12-31 €20.37 Billion €4.99 Billion 0.245x +134.83%
2022-12-31 €19.70 Billion €2.06 Billion 0.104x +231.38%
2021-12-31 €17.62 Billion €-1.40 Billion -0.079x -22.39%
2020-12-31 €14.97 Billion €-971.72 Million -0.065x +52.13%
2019-12-31 €13.45 Billion €-1.82 Billion -0.136x +75.72%
2018-12-31 €10.26 Billion €-5.73 Billion -0.559x +17.76%
2017-12-31 €7.47 Billion €-5.07 Billion -0.679x -87.46%
2016-12-31 €6.57 Billion €-2.38 Billion -0.362x --